An altered phenotype in a conditional knockout of Pitx2 in extraocular muscle

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 10, 2009, Pages 4531-4541

  Zhou, Yuefang ^a   Cheng, Georgiana ^b   Dieter, Lisa ^a   Hjalt, Tord A ^c   Andrade, Francisco H ^d   Stahl, John S ^e,f   Kaminski, Henry J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF KENTUCKY   (United States)

^e LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MM; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 1; MYOSIN HEAVY CHAIN 13; MYOSIN HEAVY CHAIN 2; MYOSIN HEAVY CHAIN 3; MYOSIN HEAVY CHAIN 4; MYOSIN HEAVY CHAIN 6; MYOSIN HEAVY CHAIN 7; MYOSIN HEAVY CHAIN 8; TRANSCRIPTION FACTOR PITX2; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; ISOPROTEIN; MESSENGER RNA; MYOSIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; EXTRAOCULAR MUSCLE; EYE MOVEMENT; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE STRAIN; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE DEVELOPMENT; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; POLYMERASE CHAIN REACTION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCADIC EYE MOVEMENT; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; EYE MOVEMENTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MYOSINS; OCULOMOTOR MUSCLES; PHENOTYPE; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 70349577528     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2950     Document Type: Article

References (54)

1. Spencer RF, Porter JD. Biological organization of the extraocular muscles. Prog Brain Res. 2005;151:43-80.
2. Leigh RJ, Zee DS. The Neurology of Eye Movements. 4th ed. New York: Oxford University Press; 2006:776.
3. Andrade FH, Porter JD, Kaminski HJ. Eye muscle sparing by the muscular dystrophies: lessons to be learned? Microsc Res Tech. 2000;48:192-203.
4. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24:802-835.
5. Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2006;116:2843-2854.
6. Diehl AG, Zareparsi S, Qian M, Khanna R, Angeles R, Gage PJ. Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. Invest Ophthalmol Vis Sci. 2006;47: 1785-1793.
7. Gage PJ, Rhoades W, Prucka SK, Hjalt T. Fate maps of neural crest and mesoderm in the mammalian eye. Invest Ophthalmol Vis Sci. 2005;46:4200-4208.
8. Lin CR, Kioussi C, O'Connell S, et al. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature. 1999;401:279-282.
9. Piedra ME, Icardo JM, Albajar M, Rodriguez-Rey JC, Ros MA. Pitx2 participates in the late phase of the pathway controlling left-right asymmetry. Cell. 1998;94:319-324.
10. Ryan AK, Blumberg B, Rodriguez-Esteban C, et al. Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature. 1998;394:545-551.
11. Hjalt TA, Semina EV. Current molecular understanding of Axenfeld- Rieger syndrome. Expert Rev Mol Med. 2005;7:1-17.
12. Brueckner JK, Porter JD. Visual system maldevelopment disrupts extraocular muscle-specific myosin expression. J Appl Physiol. 1998;85:584-592.
13. Cheng G, Mustari MJ, Khanna S, Porter JD. Comprehensive evaluation of the extraocular muscle critical period by expression profiling in the dark-reared rat and monocularly deprived monkey. Invest Ophthalmol Vis Sci. 2003;44:3842-3855.
14. McMullen CA, Andrade FH, Stahl JS. Functional and genomic changes in the mouse ocular motor system in response to light deprivation from birth. J Neurosci. 2004;24:161-169.
15. Porter JD, Khanna S, Kaminski HJ, et al. Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci U S A. 2001;98:12062-12067.
16. Bruning JC, Michael MD, Winnay JN, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998;2:559-569.
17. Gage PJ, Suh H, Camper SA. Dosage requirement of Pitx2 for development of multiple organs. Development. 1999;126:4643-4651.
18. Trask RV, Billadello JJ. Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs. Biochim Biophys Acta. 1990;1049:182-188.
19. Lyons GE, Muhlebach S, Moser A, et al. Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle. Development. 1991;113: 1017-1029.
20. McMullen CA, Hayess K, Andrade FH. Fatigue resistance of rat extraocular muscles does not depend on creatine kinase activity. BMC Physiol. 2005;5:12.
21. Porter JD, Merriam AP, Gong B, et al. Postnatal suppression of myomesin, muscle creatine kinase and the M-line in rat extraocular muscle. J Exp Biol. 2003;206:3101-3112.
22. Thompson SW. Selected histochemical and histopathological methods. Springfield, IL: Charles C Thomas. 1966.
23. Sheehan DC, Hrapchak BB. Theory and Practice of Histotechnology. Columbus, OH: Battelle Memorial Institute; 1987.
24. Green PD, Hjalt TA, Kirk DE, et al. Antagonistic regulation of Dlx2 expression by PITX2 and Msx2: implications for tooth development. Gene Expr. 2001;9:265-281.
25. Hjalt TA, Semina EV, Amendt BA, Murray JC. The Pitx2 protein in mouse development. Dev Dyn. 2000;218:195-200.
26. Cox CJ, Espinoza HM, McWilliams B, et al. Differential regulation of gene expression by PITX2 isoforms. J Biol Chem. 2002;277: 25001-25010.
27. Martin DM, Skidmore JM, Philips ST, et al. PITX2 is required for normal development of neurons in the mouse subthalamic nucleus and midbrain. Dev Biol. 2004;267:93-108.
28. Martin DM, Skidmore JM, Fox SE, Gage PJ, Camper SA. Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium. Dev Biol. 2002;252:84-99.
29. Rubinstein NA, Porter JD, Hoh JF. The development of longitudinal variation of myosin isoforms in the orbital fibers of extraocular muscles of rats. Invest Ophthalmol Vis Sci. 2004;45:3067-3072.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
31. Stahl JS. Calcium channelopathy mutants and their role in ocular motor research. Ann N Y Acad Sci. 2002;956:64-74.
32. Stahl JS, van Alphen AM, De Zeeuw CI. A comparison of video and magnetic search coil recordings of mouse eye movements. J Neurosci Methods. 2000;99:101-110.
33. Gage PJ, Suh H, Camper SA. The bicoid-related Pitx gene family in development. Mamm Genome. 1999;10:197-200.
34. Kitamura K, Miura H, Miyagawa-Tomita S, et al. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extraand periocular mesoderm and right pulmonary isomerism. Development. 1999;126:5749-5758.
35. Kitamura K, Miura H, Yanazawa M, Miyashita T, Kato K. Expression patterns of Brx1 (Rieg gene), Sonic hedgehog, Nkx2.2, Dlx1 and Arx during zona limitans intrathalamica and embryonic ventral lateral geniculate nuclear formation. Mech Dev. 1997;67:83-96.
36. Lamba P, Hjalt TA, Bernard DJ. Novel forms of Paired-like homeodomain transcription factor 2 (PITX2): generation by alternative translation initiation and mRNA splicing. BMC Mol Biol. 2008;9:31.
37. Schachat F, Briggs MM. Phylogenetic implications of the superfast myosin in extraocular muscles. J Exp Biol. 2002;205:2189-2201.
38. Brueckner JK, Itkis O, Porter JD. Spatial and temporal patterns of myosin heavy chain expression in developing rat extraocular muscle. J Muscle Res Cell Motil. 1996;17:297-312.
39. L'Honore A, Coulon V, Marcil A, et al. Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development. Dev Biol. 2007;307:421-433.
40. Hughes BW, Kusner LL, Kaminski HJ. Molecular architecture of the neuromuscular junction. Muscle Nerve. 2006;33:445-461.
41. Heinemeier KM, Olesen JL, Haddad F, et al. Expression of collagen and related growth factors in rat tendon and skeletal muscle in response to specific contraction types. J Physiol. 2007;582:1303-1316.
42. Kioussi C, Briata P, Baek SH, et al. Identification of a Wnt/Dvl/ beta-catenin3Pitx2 pathway mediating cell-type-specific proliferation during development. Cell. 2002;111:673-685.
43. Wei Q, Adelstein RS. Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling. Mol Biol Cell. 2002;13:683-697.
44. Simon AM, Hoppe P, Burden SJ. Spatial restriction of AChR gene expression to subsynaptic nuclei. Development. 1992;114:545-553.
45. Jarvinen TA, Jozsa L, Kannus P, et al. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci. 2003;116:857-866.
46. Holmberg J, Ingner G, Johansson C, Leander P, Hjalt TA. PITX2 gain-of-function induced defects in mouse forelimb development. BMC Dev Biol. 2008;8:25.
47. Allen DL, Roy RR, Edgerton VR. Myonuclear domains in muscle adaptation and disease. Muscle Nerve. 1999;22:1350-1360.
48. Newlands S, Levitt LK, Robinson CS, et al. Transcription occurs in pulses in muscle fibers. Genes Dev. 1998;12:2748-2758.
49. Harridge SD. Plasticity of human skeletal muscle: gene expression to in vivo function. Exp Physiol. 2007;92:783-797.
50. Briggs MM, Schachat F. The superfast extraocular myosin (MYH13) is localized to the innervation zone in both the global and orbital layers of rabbit extraocular muscle. J Exp Biol. 2002;205:3133-3142.
51. Andrade FH, McMullen CA. Lactate is a metabolic substrate that sustains extraocular muscle function. Pflugers Arch. 2006;452: 102-108.
52. Sclafani AM, Skidmore JM, Ramaprakash H, Trumpp A, Gage PJ, Martin DM. Nestin-Cre mediated deletion of Pitx2 in the mouse. Genesis. 2006;44:336-344.
53. Porter JD, Hauser KF. Survival of extraocular muscle in long-term organotypic culture: differential influence of appropriate and inappropriate motoneurons. Dev Biol. 1993;160:39-50.
54. Porter JD, Baker RS. Absence of oculomotor and trochlear motoneurons leads to altered extraocular muscle development in the Wnt-1 null mutant mouse. Brain Res Dev. 1997;100:121-126.